GHK-Cu copper peptide paired with Sermorelin — one of the most evidence-backed combinations for skin luminosity, collagen synthesis, texture, and firmness.
GHK-Cu (copper tripeptide-1) is one of the most studied peptides for skin — found naturally in the body but declining sharply from age 20. Paired with Sermorelin, a growth hormone-releasing hormone analogue, The Glow Protocol targets skin quality from two directions simultaneously: topical remodelling and systemic overnight repair.
GHK-Cu binds to copper ions and signals fibroblasts to increase collagen, elastin, and glycosaminoglycan production. It also activates antioxidant and anti-inflammatory pathways in the skin. Sermorelin stimulates the pituitary to release natural growth hormone — most of which is secreted overnight — amplifying the body's own repair cycles during sleep.
Women 30–55 noticing changes in skin texture, firmness, or luminosity. Particularly effective for those who have already optimised their topical routine and want to address skin quality at a systemic level.
Most patients notice texture and luminosity improvements within 6–10 weeks. Firmness changes typically become visible at 3–4 months. Sleep improvements from Sermorelin often appear within the first 3–4 weeks.
GHK-Cu has a well-established safety profile with decades of research. Side effects are uncommon and typically limited to mild injection site reactions. Your provider will review your full history before prescribing.
The Glow Protocol often does not require baseline labs. Your provider will confirm during intake review. If they request IGF-1 levels, we order them to your nearest LabCorp at no additional cost.
Yes. The Glow Protocol is commonly stacked with The Recovery Protocol. Your provider will advise on what combination makes sense for your specific goals.
Compounded peptides are prescribed off-label for wellness, performance, and recovery goals under the supervision of a licensed medical provider. They are not intended to diagnose, treat, cure, or prevent any disease.
All peptides dispensed by Lustre Health are prescription-only medications requiring a valid prescription from a licensed provider.
Compounded medications are not FDA-approved drug products. They are prepared by state-licensed 503A compounding pharmacies under USP Chapter 797 standards.
Peptides may interact with insulin, hormone therapies, and immunosuppressants. Disclose all medications to your provider.
Subcutaneous injection. Full training provided with your first shipment.